Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.850
+0.010 (0.26%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Fulcrum Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
293.74M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 80.00M | 77.20M | 2,752.05% |
| Dec 31, 2023 | 2.81M | -3.54M | -55.77% |
| Dec 31, 2022 | 6.34M | -12.82M | -66.90% |
| Dec 31, 2021 | 19.16M | 10.34M | 117.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 175.14M |
| Clinuvel Pharmaceuticals | 65.05M |
| Bicycle Therapeutics | 61.21M |
| Foghorn Therapeutics | 36.74M |
| Orchestra BioMed Holdings | 31.98M |
| AC Immune | 21.67M |
| ProQR Therapeutics | 21.05M |
| Fate Therapeutics | 6.49M |
FULC News
- 4 days ago - Kaplan Fox Advises Investors of Fulcrum Therapeutics, Inc. (FULC) to Contact the Firm Regarding a Securities Investigation - Newsfile Corp
- 6 days ago - Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (FULC) of a Securities Law Investigation - Newsfile Corp
- 9 days ago - Kaplan Fox Encourages Fulcrum Therapeutics, Inc. (FULC) Investors to Contact the Firm Regarding a Securities Investigation - Newsfile Corp
- 11 days ago - Kaplan Fox Alerts Investors of Fulcrum Therapeutics, Inc. (FULC) to a Securities Law Investigation - Newsfile Corp
- 13 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH) - GlobeNewsWire
- 13 days ago - Kaplan Fox Announces an Investigation into Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors - Newsfile Corp
- 18 days ago - Halper Sadeh LLC is Investigating Whether WEAV and FULC are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 18 days ago - Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) to Contact the Firm to Learn About Their Legal Rights - Newsfile Corp